OCHIN, INC.
PORTLAND, OR
What changed
NIH R01 · $0.6M · FRONTIERS: Foreign-Born Latinos Cancer Screening
Mar 2025Grant renewalMar 21, 2025Source filing (opens the source filing in a new tab)
Momentum
Momentum 28 out of 100, unchanged since the last recompute.
Little recent filing activity, or the events on file have decayed.
Runway (estimate)
No disclosed raise on file, so there is nothing to model from.
Stage
Grant-only
The furthest-along thing in the public record. Not a projection.
Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.
Grant to raise
Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.
- Grant
R01 · $674k · non-dilutive
Mar 1, 2025OCHIN, INC. · PI HEINTZMAN, JOHN D. · NHLBI · award ends Dec 31, 2028 · EQUITABLE: Equity in Treatment for Asthma Between Latinos and Whites
NIH RePORTER · NIH RePORTER 11044352 (opens the source filing in a new tab)
- Grant
R01 · $563k · non-dilutive
May 20, 2022OREGON HEALTH & SCIENCE UNIVERSITY · PI HEINTZMAN, JOHN D. · NCI · award ends Apr 30, 2027 · FRONTIERS: Foreign-Born Latinos Cancer Screening
NIH RePORTER · NIH RePORTER 11074643 (opens the source filing in a new tab)
Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources